Notice of Participation of NCATS in RFA-HL-14-012 Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood and Sleep Technologies with Small Commercial Markets (R44)

Notice Number: NOT-TR-13-006

Release Date: April 16, 2013

RFA-HL-14-012

National Center for Advancing Translational Sciences (NCATS)

The purpose of this Notice is to inform potential applicants of the National Center for Advancing Translational Science (NCATS) s participation, effective immediately, in RFA-HL-14-012 "Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood and Sleep Technologies with Small Commercial Markets (R44).

The following sections of RFA-HL-14-012 have been updated to reflect the participation of NCATS in this FOA:

Components of Participating Organizations

National Heart, Lung, and Blood Institute (NHLBI)
National Center for Advancing Translational Sciences (NCATS)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.350

Funds Available and Anticipated Number of Awards

NCATS intends to commit up to $500,000 in FY14 funds.

Scientific/Research Contact(s)


Lili M. Portilla, MPA
Director, Office of Strategic Alliances
National Center for Advancing Translational Sciences (NCATS)
Phone: 301-402-0304
Fax: 301-480-3661
Email: [email protected]

David J. Eckstein, Ph.D.
Senior Health Scientist Administrator
Office of Rare Diseases Research
National Center for Advancing Translational Sciences (NCATS)
Phone: 301-402-4336             
Fax: 301-480-9655
Email: [email protected]

Financial/Grants Management Contact(s)

Long Nguyen
Office of Grants Management
National Center for Advancing Translational Sciences (NCATS)
Phone: 301-402-6737
Fax: 301-480-3777
Email:  [email protected]

All other aspects of this FOA remain unchanged.

Please direct all inquiries to:

Lili M. Portilla, MPA
Director, Strategic Alliances
Director, Office of Strategic Alliances
National Center for Advancing Translational Sciences (NCATS)
Phone: 301-402-0304
Fax: 301-480-3661
Email: [email protected]